Cannula Only, Because It's Our Policy? Consent You Announce at the Chair Isn't Consent

Назад к новостям
Автор: Editorial Team2026-09-21

The r/MedSpa post "Cannula before filler?" is written by a filler patient of fifteen years who moved states, found a new practice, and discovered at the moment of treatment that the injector uses a technique the practice requires and that had never come up at the consultation. She was told she could not decline it because it was safer and it was their policy. She asked for it to be removed almost immediately, was left with a week of swelling and the only bruising she had from the appointment, and then asked for a refund on the syringe that was never used. The practice refused, on the grounds that it was what she ordered.

That refusal is the part worth examining here, because it is a policy failure rather than a clinical one — and it is one that any practice can avoid with two documents it probably already has.

A policy announced at the chair is not consent

The clinical merits of one injection technique over another are not something this article will adjudicate; that belongs to the treating provider, and any patient with that question should ask a qualified injector or a physician rather than a blog. What is squarely in the business domain is the sequence in which the policy was disclosed.

Consent is a process with a position in time. It happens before the client commits money and schedule, when she still has the ability to choose a different provider, a different treatment, or a different day. A practice requirement that materially changes what the appointment will involve — the instruments, the discomfort, the recovery, the areas treated — is exactly the kind of thing that belongs in the consultation, along with the alternative. Presenting it for the first time once the client is in the chair converts a choice into an ultimatum, and the sentence that gives it away is the one she reported: she could not refuse because it was their policy.

The fix is not complicated and it does not require abandoning the technique. It requires stating the practice policy in the consultation, writing it into the treatment plan with the rationale the provider would give a colleague, and stating what happens if the client declines — including the option to treat different areas or to be referred elsewhere. A practice that does this will occasionally lose a booking. A practice that does not eventually loses the patient, the deposit argument, and a public account of the appointment, which is a much more expensive outcome than a consultation that ran ten minutes longer.

One detail from the post is worth flagging to any front desk: the patient said the policy was never mentioned at the initial consultation and only surfaced when it was time to inject. That gap is almost never a deliberate concealment. It is usually that the policy lives in the provider's head, not on the intake form, because the staff who booked the appointment were not the person who would perform it. Which is the argument for writing it down: a policy that only exists in one person's practice habits cannot be disclosed by anyone else.

The unused syringe: why "that's what I ordered" fails

The refusal to refund is a pricing-policy question, and it is one where the stated rationale does not hold up. The practice paid for two and a half syringes; the client received one and a half. The fifth unit was never opened, never injected, and never touched. From the practice's accounting view, it is inventory that may or may not be returnable depending on how the product was sourced. From the client's view, it is money paid for something she did not receive.

Those two views can be reconciled, but only in advance. The policy a practice needs covers three situations, and most practices have written down none of them.

Treatment stopped before all planned product is used. State, at the point of sale, what happens to the unused portion: refunded in full, converted to credit, or subject to a restocking deduction if the product genuinely cannot be returned. Whichever it is, the client should be able to read it before paying, not after disagreeing.

Treatment stopped because the client declined a required technique. This is closer to the case in the post, and the fair rule is the one that acknowledges the practice's own role: if the policy was not disclosed before the appointment, the unused product is refunded, because the practice's process is what prevented delivery. If it was disclosed and the client changed her mind anyway, the credit-or-deduction terms apply. Making that distinction in writing is what stops the front desk from having to invent an answer under pressure.

Prepaid packages and courses. Define what happens to a multi-session package when one session is stopped mid-way, and whether the remainder is refundable pro rata. This is the same principle at a larger scale, and it is the version that ends up in small-claims court most often, because the numbers are bigger.

The reason to write these down is not primarily legal. It is that the alternative is what happened here: a fifteen-year injectable patient, an $800 dispute, and a decision to ask a public forum whether the practice was behaving normally. The cost of the refund was one unit of product. The cost of the refusal is a patient who will tell this story for years and a post that will be read by people researching that market.

The version of this that ends well

Three changes would have turned this appointment into a non-event. The technique policy appears in the consultation, in writing, with its rationale and its alternative. The refund rule for unused prepaid product appears at the point of sale, so nobody is negotiating it afterward. And when a client stops a treatment mid-way and asks for the unused portion back, the default answer is yes for anything that was never opened — with the accounting discussion handled internally rather than passed to the client as her problem.

None of that requires a practice to change how it injects. It requires the practice to decide, in advance, which parts of its process are non-negotiable, and to disclose them at the moment the client can still make a decision. A policy that is genuinely about safety can be explained early. One that only works when it is announced late is a policy problem wearing a clinical justification, and it is the reason a routine appointment becomes a post that a practice cannot answer.